======= EAF2 ======= == Gene Information == * **Official Symbol**: EAF2 * **Official Name**: ELL associated factor 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55840|55840]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96CJ1|Q96CJ1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EAF2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EAF2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607659|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a transcriptional transactivator of TCEA1 elongation activity (By similarity). Acts as a transcriptional transactivator of ELL and ELL2 elongation activities. Potent inducer of apoptosis in prostatic and non-prostatic cell lines. Inhibits prostate tumor growth in vivo. {ECO:0000250, ECO:0000269|PubMed:12446457, ECO:0000269|PubMed:12907652, ECO:0000269|PubMed:16006523}. |EAF| |ELL-EAF complex| |negative regulation of epithelial cell proliferation involved in prostate gland development| |regulation of epithelial cell proliferation involved in prostate gland development| |transcription elongation factor complex| |negative regulation of reproductive process| |transcription elongation from RNA polymerase II promoter| |DNA-templated transcription, elongation| |negative regulation of epithelial cell proliferation| |regulation of reproductive process| |negative regulation of cell growth| |negative regulation of growth| |RNA polymerase II regulatory region sequence-specific DNA binding| |regulation of epithelial cell proliferation| |nuclear speck| |regulation of cell growth| |DNA-binding transcription activator activity, RNA polymerase II-specific| |transcription by RNA polymerase II| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |regulation of growth| |negative regulation of cell population proliferation| |apoptotic process| |negative regulation of developmental process| |programmed cell death| |cell death| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of multicellular organismal process| |positive regulation of transcription by RNA polymerase II| |organic cyclic compound biosynthetic process| |positive regulation of transcription, DNA-templated| |regulation of cell population proliferation| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp134|MS023 2μM R03 exp134]]|-1.76| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16098 * **Expression level (log2 read counts)**: 2.33 {{:chemogenomics:nalm6 dist.png?nolink |}}